Borrelia parkeri

From WikiMD's WELLNESSPEDIA

Borrelia parkeri is a species of spirochete bacteria in the genus Borrelia. It is named after Mazyck P. Ravenel and Joseph E. Parker, who first isolated the bacterium. This bacterium is known to cause tick-borne relapsing fever (TBRF) in humans.

Taxonomy[edit]

Borrelia parkeri is a member of the Borrelia genus, which is part of the larger Spirochaetaceae family. The genus Borrelia is named after French biologist Amédée Borrel. The species name, parkeri, honors the scientists who first isolated the bacterium.

Morphology[edit]

Like other spirochetes, Borrelia parkeri is a long, slender, and spiral-shaped bacterium. It is Gram-negative, meaning it does not retain the violet stain used in the Gram stain procedure. Instead, it takes up the red counterstain.

Pathogenesis[edit]

Borrelia parkeri is transmitted to humans through the bite of infected Ornithodoros ticks. Once in the human body, the bacterium can cause tick-borne relapsing fever. This disease is characterized by recurring episodes of fever, headache, muscle and joint aches, and nausea.

Diagnosis and Treatment[edit]

Diagnosis of Borrelia parkeri infection is typically based on clinical symptoms and confirmed by laboratory testing. The most common test is a blood smear, which can reveal the presence of the bacterium. Treatment usually involves antibiotics, such as doxycycline or penicillin.

Prevention[edit]

Prevention of Borrelia parkeri infection primarily involves avoiding tick bites. This can be achieved by wearing protective clothing and using insect repellents when in areas where ticks are common.

See Also[edit]


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.